目的进一步认识反应停在治疗恶性浆细胞疾病时可能出现的不良反应。
Objective To study the side effects of thalidomide in treating malignant plasmacyte disease.
目的评价外周血干细胞移植(PBSCT)治疗恶性浆细胞病的安全性和有效性。
Objective To evaluate the safety and efficacy of peripheral blood stem cell transplantation (PBSCT) in patients with malignant plasma cell diseases.
方法总结应用反应停治疗恶性浆细胞疾病时见到的4例罕见不良反应的患者，并进行相关文献复习。
Methods the rare side effects of thalidomide in treating 4 cases of malignant plasmacyte disease were investigated and the pertinent literatures were reviewed.
多发性骨髓瘤是一种浆细胞恶性增生，单克隆免疫球蛋白合成异常的恶性疾病。
Multiple myeloma is a vicious monoclonal B - cell disease with plasmacyte proliferating slowly.
确诊病例包括：孤立性浆细胞瘤1例，转移癌24例，结核5例，多发性骨髓瘤4例，恶性淋巴瘤2例，骨感染3例，3例误诊。
The confirmed cases included: 1 case of solitary plasmacytoma, 24 metastasis lesions, 5 tuberculosis, 4 multiple myeloma, 2 malignant lymphoma and 3 bony infection. 3 cases were misdiagnosed.
确诊病例包括：孤立性浆细胞瘤1例，转移癌24例，结核5例，多发性骨髓瘤4例，恶性淋巴瘤2例，骨感染3例，3例误诊。
The confirmed cases included: 1 case of solitary plasmacytoma, 24 metastasis lesions, 5 tuberculosis, 4 multiple myeloma, 2 malignant lymphoma and 3 bony infection. 3 cases were misdiagnosed.
应用推荐